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Overproduction of oxygen free radicals and decreased antioxidant capacity has been 
shown to be a hallmark of severe sepsis more than 20 years ago 1. In the late 1990’s 
there was a surge of randomised controlled trials trying to modulate this important 
host response, with predictably negative results 2. None of these trials stratified the 
patients according to their oxygen free radical production, hence it is not surprising 
that the potential beneficial effect has been diluted in the process 3,4. 
Because of these negative studies, clinical researchers became vary of this treatment 
modality, however there has been an ongoing interest in this part of the 
pathophysiology of sepsis and septic shock in cellular and molecular level. 
In the current issue of the journal, Montini et al. report the results of their pilot 
study, which adds important data to our understanding of the time-course and 
potential importance of reactive oxygen species metabolites in sepsis and septic 
shock 5. They found that there was a significant evolution in the reactive oxygen 
species metabolites (ROM) levels and that diminishing ROM levels showed a 
negative correlation with the corresponding daily SOFA score and predicted time of 
death. The authors speculated that this phenomenon could be due to on-going 
mitochondrial dysfunction as ROMs originating from plasma and mitochondrium 
showed a growing imbalance as the time passed. 
Worsening daily SOFA scores, increased level of oxidative stress and reduced level 
of antioxidant capacity have been previously shown to correlate with outcome 1. 
This pilot study is the first to actually monitor the evolution of ROMs during the 
whole course of ICU stay and in that it provides very important insight. 
Patients in this pilot study were recruited between the 5th-8th day of ICU stay, with 
new onset of severe sepsis or septic shock according to the 2012 consensus 
definition 6. They were most likely suffering from ICU acquired infections such as 
ventilator-associated pneumonia, catheter related urinary tract infection or ICU 
acquired bacteraemia. Unsurprisingly, most of them suffered from primarily Gram-
positive infections and majority of the patients had polymicrobial infection 5. There 
is a growing body of evidence which points towards worse outcomes if the patient 
suffers from a “second-hit” infection of Gram-positive origin 7 and interestingly the 
results of Montini et al. may shed some light to one of the possible mechanisms 
behind this observation. 
Gram positive organisms are frequently isolated in clinical samples on the intensive 
care unit, such as methicillin resistant Staphylococcus aureus and possess a 
sophisticate repertoire to avoid neutrophil killing even if phagocytosis has taken 
place 8. Bacterial pathogens often employ two-component systems (TCSs), typically 
consisting of a sensor kinase and a response regulator, to control expression of a set 
of virulence genes in response to changing host environments. In Staphylococcus 
aureus, the SaeR/S TCS is essential for in vivo survival of the bacterium. In an 
elegant study Guerra et al. demonstrated that the SaeR/S TCS found in 
Staphylococcus aureus species do not inhibit neutrophil superoxide (O2−) 
production, however, subsequent neutrophil ROS production was significantly 
reduced and resulted in decreased production of hypochlorous acid/hypochlorite 
anion (HOCl/−OCl) 9. Staphylococcus aureus already ingested by neutrophils not 
only undermine oxidant attack but also repair oxidative damage incurred within the 
immune system’s effector cells. SaeR/S TCS together with other signalling pathways 
can contribute to the modulation of stress response genes such as Methionine 
sulfoxide reductases (Msr) 10. Msr are highly conserved enzymes that support 
oxidative repair in a wide range of organisms and contribute to survival of bacteria 
within neutrophils 8.  The absence of Msr activity increased the susceptibility of 
Staphylococcus aureus to reagent H2O2 and HOCl and also to the antimicrobial 
effects of neutrophils 10. Together, the combined effects of limiting and repairing 
oxidant damage promote survival of Gram positive bacteria within neutrophils 10.  
The results of the clinical study by Montini et al. can add another puzzle to this 
jigsaw and demonstrate that reduced level of oxidative stress and resulting 
ineffective bacterial clearance can be demonstrated in the patients with highest risk 
of unfavourable outcome. Their observation of significantly reduced ROM levels at 
the last stage of severe sepsis and septic shock not only can signify exhaustion of 
mitochondrial function but also inadequate host response to the bacterial invasion. 
There are several questions remain following this pilot study. One of them is 
whether the results can be replicated in a much larger cohort? We have seen time 
and again, that results of small, exploratory studies could not be confirmed in larger 
trials and this risk runs high with the work of Montini et al 5.  
The potential role of ROMs in determining the outcome is intriguing and the next 
logical question is: how can we manipulate this phenomenon? Is there a potential to 
restore healthy mitochondrial ROM levels to improve the outcome of the critically ill 
septic patient?  
Paradoxically the answer might be to reduce overall oxygen exposure levels and to 
reduce global oxidative stress and the disturbance of innate immunity. Systemic 
hyperoxia has been shown to cause peripheral vasoconstriction and, in animal 
models, increases production of reactive oxygen species. The PROXI trial 
(Perioperative Oxygen Fraction– Effect on Surgical Site Infection and Pulmonary 
Complications After Abdominal Surgery) and more recently the Oxygen-ICU study 
reported an association between high fraction of inspired oxygen (FiO2) and an 
increase in long-term mortality in the perioperative and critical care setting 11,12. 
The Oxygen-ICU study very convincingly shown a significant reduction in new 
infections and new incidence of shock, when conservative levels of oxygen therapy 
was applied on the ICU 12. Interestingly, the Kaplan-Meier curve started to diverge 
between the conservative and conventional oxygen administration strategy groups 
exactly at the time point where Dr Montini recruited their patients into their pilot 
study. Is it possible that the serial measurement of ROMs could help us minimising 
external oxygen exposure, whilst maintaining mitochondrial homeostasis? There 
are many exciting and important questions waiting to be answered, before the role 
of reactive oxygen species in sepsis is fully elucidated. 
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